Skip to main content

Table 1 Patient characteristics, anthropometric profile and glycaemic profile

From: Impact of comorbid polycystic ovarian syndrome and gestational diabetes mellitus on pregnancy outcomes: a retrospective cohort study

 

GDM+PCOS+

N = 326

GDM+PCOS0

N = 1215

p-value

Mean age (years)

29.5 (±4.4)

31.5 (±5.3)

<0.001

Ethnicity

  

<0.001

 Caucasian

124 (37.8)

266 (21.8)

 

 Non Caucasian

204 (62.2)

951 (78.2)

 

  Africans

6 (1.8)

40 (3.2)

 

  Southeast Asians

30 (9.2)

257 (21.2)

 

  South Asians

42 (12.8)

226 (18.6)

 

  Pacific Islanders

16 (4.8)

88 (7.3)

 

  Middle-East

96 (29.4)

312 (25.7)

 

  South Americans

4 (1.2)

15 (1.2)

 

  Indigenous

6 (1.8)

10 (0.8)

 

  Other

4 (1.2)

3 (0.2)

 

Gravidity

  

<0.001

 Primigravidity

104 (31.9)

244 (20)

 

 Multigravidity

222 (68.1)

973 (80)

 

  <5 pregnancies

180 (55.2)

740 (60.1)

 

  ≥5 pregnancies

42 (12.9)

233 (19.1)

 

Smoking status

  

0.020

 Smokers

36 (11.1)

87 (7.2)

 

 Non-smokers

288 (88.9)

1129 (92.8)

 

Family History of diabetes

  

0.950

 Yes

150 (46.6)

562 (46.8)

 

 No

172 (53.4)

639 (53.2)

 

Past history of GDMa

  

<0.001

 Yes

32 (18.9)

305 (36.3)

 

 No

138 (81.1)

536 (63.7)

 

Mean Body Mass Index (kg/m2)

31.5 (±6.7)

27.7 (±9.4)

<0.001

Body Habitus

  

<0.001

 Non-obese

200 (62.5)

836 (68.5)

 

 Obesity (BMI>30)

120 (37.5)

384 (31.5)

 

Mean gestational weight gain (kg)

12.6 (±7.7)

11.5 (±7.4)

0.016

Previous insulin use

  

0.357

 Yes

30 (9.2)

144 (11.8)

 

 No

296 (90.8)

1072 (88.2)

 

Use of Metformin during current pregnancy

  

0.005

 Yes

64 (20.5)

151 (12.4)

 

 No

248 (79.5)

1064 (87.6)

 

Insulin used during current pregnancy

  

<0.001

 Yes

178 (57.1)

536 (44.1)

 

 No

134 (42.9)

679 (55.9)

 

Management during current pregnancy

  

<0.001

 Nil medications

132 (42.3)

666 (54.8)

 

 Metformin only

47 (15.1)

98 (8.1)

 

 Insulin only

116 (37.2)

399 (32.8)

 

 Combination

17 (5.4)

52 (4.3)

 

Mean dose of prandial insulin at the end of pregnancy (units)

37.7 (±59.5)

35.4 (±39.2)

0.425

Mean dose of basal insulin at the end of pregnancy (units)

18.5 (±23.9)

17.0 (±17.3)

0.529

Mean fasting BGLb on OGTT (mmol/L)

5.4 (±3.6)

5.1 (±0.7)

0.006

Mean 1 hour BGLb on OGTT (mmol/L)

9.7 (±1.7)

9.9 (±1.8)

0.225

Mean 2 hour BGLb on OGTT (mmol/L)

7.7 (±1.7)

7.8 (±2.2)

0.469

Mean HbA1c at diagnosis

5.2 (±0.4)

5.2 (±0.4)

0.539

  1. aNulliparous women were not included in this analysis; bBlood glucose level